Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.185
+0.075 (6.76%)
Dec 3, 2025, 2:00 PM EST - Market open
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $37.99 million as of December 3, 2025. Its market cap has decreased by -76.42% in one year.
Market Cap
37.99M
Enterprise Value
1.88M
1-Year Change
-76.42%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $37.99M, a decrease of -89.33%. That is a compound annual growth rate of -74.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 38.80M | -54.83% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 947.22B |
| Johnson & Johnson | 494.72B |
| AbbVie | 397.86B |
| UnitedHealth Group | 292.78B |
| AstraZeneca | 283.73B |
| Merck & Co. | 252.74B |
| Novartis AG | 249.18B |
| Abbott Laboratories | 222.59B |